A new study published in Translational Exercise Biomedicine (ISSN: 2942-6812), an official partner journal of International Federation of Sports Medicine (FIMS), reveals that a progressive, multi-component exercise program, enhanced by wearable sensor technology, can significantly counteract the debilitating effects of frailty in older adults. The 12-week intervention led to remarkable improvements not only in physical strength and balance, but also in cognitive abilities and overall quality of life, presenting an effective and practical strategy for community health management in an aging global population.

In an exciting exploration of environmental sustainability, researchers at Zhaoqing University, China, have uncovered groundbreaking insights into the carbon dynamics of waterlogged pond fields. Led by Dr. Guodong Yuan from the Guangdong Provincial Key Laboratory of Eco-Environmental Studies and Low-Carbon Agriculture in Peri-Urban Areas and the Guangdong Technology and Equipment Research Center for Soil and Water Pollution Control, this study, titled "Unveiling Carbon Dynamics in Year-Round Waterlogged Pond Fields: Insights into Soil Organic Carbon Accumulation and Sustainable Management," offers a fresh perspective on how these unique ecosystems can contribute to carbon sequestration and sustainable land management.

The Satsuma mandarin is one of the world's most widely cultivated citrus fruits, prized for its seedlessness, sweetness, and adaptability. 

Micro/nanomotors (MNMs) have become a transformative force in biomedical engineering, playing a pivotal role in advancing next-generation drug delivery systems. These tiny propulsion systems are categorized by their actuation mechanisms, with gas-driven MNMs standing out due to their ability to harness chemically generated micro/nano-scale thrust for autonomous motion. By leveraging their dynamic self-propulsion and unique bio-interactive behaviors, gas-driven MNMs can efficiently navigate complex biological barriers, offering groundbreaking therapeutic solutions for cancer treatment, thrombolysis, and targeted drug delivery. This review first examines the fundamental propulsion mechanisms of gas-driven MNMs, then highlights their latest breakthroughs in overcoming physiological obstacles. Finally, it evaluates their future potential and clinical advantages, providing critical insights to drive innovation and accelerate their translation into real-world medical applications.

Currently, the development of low-reflection electromagnetic interference (EMI) shielding composite materials for mitigating secondary electromagnetic wave pollution has become a major research focus. However, achieving thinness, high toughness, low reflectivity, and multifunctionality in flexible EMI shielding films remains a challenge. To address this issue, Benliang Liang and Luting Yan from Beijing Jiaotong University, in collaboration with Lan Zhang from Luoyang Institute of Science and Technology, have introduced a "magnetic-electric" Janus structure EMI shielding composite film composed of MXene nanosheets, carbonized ZIF67 (CZIF67) nanoparticles and aramid nanofibers (ANF), balancing thinness(80 μm), high-strength-toughness composite film (110±7 MPa tensile strength, 21% strain, 14.91±0.9 MJ·m⁻³ toughness), (4.3–4.5 dB in 8.2–9.6 GHz) with 44.8 dB SET in the X-band. In addition, This multifunctional material simultaneously integrates electrothermal/photothermal conversion, fire-alarm response, and infrared stealth capabilities, demonstrating exceptional potential for next-generation wearable electronics and harsh-environment applications.

Ulcerative colitis (UC), a prevalent chronic inflammatory bowel disease, faces limitations in current treatments due to poor efficacy and side effects. Emodin (EMO), a natural anti-inflammatory compound, shows promise but is hindered by low solubility and bioavailability. A research team led by Prof. Xueye Chen from Ludong University developed a novel micromixer combined with machine learning to enable one-step synthesis of targeted emodin liposomes (Apt-EMO@Lip), significantly enhancing therapeutic efficiency and paving new avenues for UC treatment.